This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
QINGDAO, China and
Nov. 29, 2012 /PRNewswire/ -- Synutra International, Inc. (NASDAQ: SYUT), ("Synutra" or the "Company"), which owns subsidiaries in
China that produce, market and sell nutritional products for infants, children and adults, today announced that the Company will attend Oppenheimer & Co.'s 23rd Annual Healthcare Conference, to be held
December 12-13, 2012 at the Waldorf Astoria Hotel in
New York. Management is scheduled to present at
11:10 a.m. ET on
Wednesday, December 12, 2012 and to meet with institutional investors throughout the day.
For additional information, please contact your Oppenheimer institutional sales representative or Synutra's investor relations department at 301-840-3881.
About Synutra International, Inc.
Synutra International, Inc. (Nasdaq: SYUT) is a leading infant formula company in
China. It principally produces, markets and sells its products through its operating subsidiaries under the "Shengyuan" or "Synutra" name, together with other complementary brands. It focuses on selling premium infant formula products, which are supplemented by more affordable infant formulas targeting the mass market as well as other nutritional products and ingredients. It sells its products through an extensive nationwide sales and distribution network covering all provinces and provincial-level municipalities in mainland
China. As of
September 30, 2012, this network comprised over 680 independent distributors and over 730 independent sub-distributors who sell Synutra products in over 63,000 retail outlets.
SOURCE Synutra International, Inc.